Status:
COMPLETED
Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborating Sponsors:
Department of Urology
Conditions:
Constipation
Eligibility:
All Genders
4-21 years
Phase:
EARLY_PHASE1
Brief Summary
HYPOTHESIS: Is MiraLAX an effective treatment of pediatric urinary urge syndrome? OBJECTIVE: Polyethylene glycol (PEG) is common first-line therapy for urinary symptoms despite minimal evidence-bas...
Detailed Description
Urge Syndrome (US) is the most common non-neurogenic voiding dysfunction in children beyond the usual age for toilet training, and is characterized by urinary frequency and urgency, holding maneuvers,...
Eligibility Criteria
Inclusion
- Toilet-trained with a history of urinary tract infection
- Vesicoureteral reflux
- Urinary incontinence
- Daily frequency and urgency
- Diurnal incontinence.
Exclusion
- Children who are below 4 years old as they may still not be toilet-trained;
- Children with encopresis
- Children with anorectal malformations
- Children with neurologic disorders
Key Trial Info
Start Date :
December 10 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 22 2014
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT00765557
Start Date
December 10 2007
End Date
July 22 2014
Last Update
January 15 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.